New Jersey will be claiming our place as a global biotech hub at BIO International, the world’s largest biotechnology conference, in Philadelphia from June 3 to June 6. The industry event will feature more than 7,000 companies, 1,800 exhibitors and 16,000 attendees from 67 countries.
Choose New Jersey, BioNJ and the New Jersey Economic Development Authority (NJEDA), are leading New Jersey’s showcase at the annual conference. The NJ Delegation, comprised of our state’s industry leaders, research universities, trade associations, and business service professionals, will demonstrate the breadth and diversity of New Jersey’s life sciences community. The NJ Pavilion (Booth #1501) will be situated at the entrance of the Philadelphia Convention Center’s main exhibit hall floor, attracting companies to discover what New Jersey has to offer.
BIO International brings together biotech and pharma leaders and entrepreneurs for knowledge-sharing, partnering opportunities, the ability to find funding and services and to learn more about business location advantages. Considering the proximity of the conference in Philadelphia, we see this year as our time to shine. We want life sciences companies to be inspired by the innovation here, built upon a 125-year history of delivering lifesaving medicine.
New Jersey has always been home to discovery. We welcome big ideas that bring transformative therapies, novel medicines and disruptive technologies to market. Our innovation ecosystem includes strong industry synergy, venture capital funding, access to leading universities, proximity to research hospitals and concentration of top talent. This year, we will be focusing on New Jersey’s available space and thriving entrepreneurial environment.
Choose New Jersey, along with our partners at BioNJ and NJEDA, are eagerly awaiting the opportunity to tell our story of innovation to the world and spotlight New Jersey’s influence on the industry.
According to Tim Sullivan, CEO of NJEDA, “BIO 2019 presents a unique opportunity to promote New Jersey’s robust startup culture. With a dozen of the world’s largest pharmaceutical companies having a headquarters or a presence in the Garden State and access to a highly-talented workforce, it’s easy to see why emerging biotechnology companies are choosing to call New Jersey ‘home.’ We are continuing to advance initiatives in support of Governor Murphy’s vision for making New Jersey the State of Innovation, and look forward to seeing how New Jersey companies will impact the global marketplace for years to come.”
Debbie Hart, president and CEO of BioNJ, comments, “Having the BIO 2019 convention right across the Delaware River is advantageous to showcase New Jersey’s vibrant life sciences ecosystem – delivering lifechanging therapies and cures for patients around the globe. The NJ Pavilion’s prominent presence will allow us to demonstrate that our state has the resources and support needed to help companies of all sizes grow and prosper.”
With more than 65 participants in the NJ Pavilion, we are excited to once again put New Jersey’s best foot forward. We are confident that BIO 2019 will be one of our most successful years to date.
To access more business news, visit NJB News Now.Related Articles: